These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10713644)

  • 1. Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
    Amano H; Morimoto S; Kaneko H; Tokano Y; Takasaki Y; Hashimoto H
    Lupus; 2000; 9(1):26-32. PubMed ID: 10713644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T; Igarashi T; Shimizu A; Itoh Y
    J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.
    Baba S; Katsumata Y; Kawaguchi Y; Gono T; Sugiura T; Kanno T; Hara M; Yamanaka H
    BMC Womens Health; 2011 Jun; 11():28. PubMed ID: 21663683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
    Opastirakul S; Chartapisak W
    Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of lymphocyte function associated antigen-1, intercellular adhesion molecule-1 on peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Kaneko H; Tokano Y; Hashimoto H; Hirose S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):60-8. PubMed ID: 8681028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy.
    Suzuki K; Tanaka H; Tsugawa K; Ito E
    Tohoku J Exp Med; 2006 Apr; 208(4):355-9. PubMed ID: 16565599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
    Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
    Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
    Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective suppression of resting B cell function in patients with systemic lupus erythematosus treated with cyclophosphamide.
    Takeno M; Suzuki N; Nagafuchi H; Mizushima Y; Sakane T
    Clin Exp Rheumatol; 1993; 11(3):263-70. PubMed ID: 8353980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumatosis cystoides intestinalis associated with intravenous pulse cyclophosphamide treatment for systemic lupus erythematosus].
    Nonaka D; Higuchi M; Yoshizawa S; Horiuchi T; Nakashima H; Niho Y
    Ryumachi; 1998 Aug; 38(4):605-10. PubMed ID: 9785989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of therapies on childhood systemic lupus erythematosus].
    Kurosawa R; Umezawa R; Kobayashi Y; Nakajima S; Miyamae T; Ito S; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
    Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three cases of childhood-onset male systemic lupus erythematosus (SLE) successfully treated with a combination of pulse methylprednisolone and pulse cyclophosphamide].
    Nakajima S; Umebayashi H; Kurosawa R; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):343-8. PubMed ID: 16276048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.
    Suárez A; López P; Gómez J; Gutiérrez C
    Ann Rheum Dis; 2006 Nov; 65(11):1512-7. PubMed ID: 16606650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.